{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:22:27Z","timestamp":1776601347199,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.drugalcdep.2008.12.012","type":"journal-article","created":{"date-parts":[[2009,2,24]],"date-time":"2009-02-24T16:46:24Z","timestamp":1235493984000},"page":"176-182","source":"Crossref","is-referenced-by-count":22,"title":["Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection"],"prefix":"10.1016","volume":"101","author":[{"given":"Steven L.","family":"Batki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"Canfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ploutz-Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2008.12.012_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2036.2005.02602.x","article-title":"Review article: chronic hepatitis C\u2014natural history and cofactors","volume":"22","author":"Alberti","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib2","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1086\/588297","article-title":"Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994\u20132004","volume":"46","author":"Amon","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib3","series-title":"Beck Anxiety Inventory","author":"Beck","year":"1993"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/jhep.2002.31311","article-title":"Relationship of health-related quality of life to treatment adherence and sustained virological response in chronic hepatitis C patients","volume":"35","author":"Bernstein","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.drugalcdep.2008.12.012_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0740-5472(99)00084-7","article-title":"Depression among needle exchange program and methadone maintenance clients","volume":"18","author":"Brienza","year":"2000","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.510290124","article-title":"Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy","volume":"29","author":"Bonkovsky","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jhep.2005.11.046","article-title":"Depression, anemia and health-related quality of life in chronic hepatitis C","volume":"44","author":"Dan","year":"2006","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2008.12.012_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2105\/AJPH.91.1.23","article-title":"Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City","volume":"91","author":"Diaz","year":"2001","journal-title":"Am. J. Public Health"},{"issue":"3","key":"10.1016\/j.drugalcdep.2008.12.012_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/09595230412331289428","article-title":"Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire","volume":"23","author":"Deering","year":"2004","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib10","series-title":"Structural Clinical Interview for DSM-IV Axis I (SCID-I)","author":"First","year":"1997"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib11","series-title":"Structural Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II)","author":"First","year":"1997"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1572-0241.2001.03473.x","article-title":"Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C","volume":"96","author":"Fontana","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.510270132","article-title":"Chronic hepatitis C causes a significant reduction in quality of life in the absence of cirrhosis","volume":"27","author":"Foster","year":"1998","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.drugalcdep.2008.12.012_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0188-4409(03)00003-1","article-title":"Health-related quality of life and depression in patients with chronic hepatitis C","volume":"34","author":"Gallegos-Orozco","year":"2003","journal-title":"Arch. Med. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2008.12.012_bib15","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"18","author":"Garfein","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"issue":"5","key":"10.1016\/j.drugalcdep.2008.12.012_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2105\/AJPH.86.5.655","article-title":"Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, and human immunodeficiency, and human T-lymphotrophic viruses","volume":"86","author":"Garfein","year":"1996","journal-title":"Am. J. Public Health"},{"issue":"2","key":"10.1016\/j.drugalcdep.2008.12.012_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08039480600583639","article-title":"Drug addiction in hepatitis C patients leads to a lower quality of life","volume":"60","author":"Gjeruldsen","year":"2006","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.genhosppsych.2005.06.006","article-title":"Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors","volume":"27","author":"Golden","year":"2005","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib19","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/345554","article-title":"Hepatitis C virus seroconversion among young injection srug users: relationships and risks","volume":"186","author":"Hahn","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/jhep.2001.25759","article-title":"Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco","volume":"34","author":"Hahn","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.drugpo.2007.01.016","article-title":"HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection","volume":"18","author":"Hagan","year":"2007","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib23","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/01.psy.0000145824.82125.a8","article-title":"Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C","volume":"66","author":"Hauser","year":"2004","journal-title":"Psychosom. Med."},{"issue":"9","key":"10.1016\/j.drugalcdep.2008.12.012_bib24","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1572-0241.2001.04133.x","article-title":"Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C","volume":"96","author":"Hussain","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.drugalcdep.2008.12.012_bib25","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s10620-006-9708-x","article-title":"Fatigue and health-related quality of life (HRQOL) in chronic hepatitis C virus infection","volume":"52","author":"Kallman","year":"2007","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.drugalcdep.2008.12.012_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00004836-200607000-00012","article-title":"The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life","volume":"40","author":"Lim","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.drugalcdep.2008.12.012_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1300\/J069v17n03_07","article-title":"Psychiatric comorbidity in methadone maintained patients","volume":"17","author":"Mason","year":"1998","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0168-8278(00)00026-X","article-title":"The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity","volume":"34","author":"McHutchison","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib29","series-title":"The Addiction Severity Index-\u201cLite\u201d (ASI-\u201cLite\u201d)","author":"McLellan","year":"1997"},{"issue":"4","key":"10.1016\/j.drugalcdep.2008.12.012_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1467-842X.2001.tb00594.x","article-title":"Quality of life in HCV-infection: Lack of association with ALT levels","volume":"25","author":"Miller","year":"2001","journal-title":"Aust. N. Z. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000090426","article-title":"Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs","volume":"12","author":"Millson","year":"2006","journal-title":"Eur. Addict. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2008.12.012_bib32","first-page":"77","article-title":"Sustained virological response is associated with improved health-related quality of life in relapsed chronic hepatitis C patients","volume":"19","author":"Neary","year":"1999","journal-title":"Sem. Liver Dis."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib33","series-title":"42nd Annual Meeting of the Infectious Diseases Society of America","article-title":"Estimated global prevalence of hepatitis C virus infection","author":"Perez","year":"2004"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","article-title":"Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C","volume":"34","author":"Poynard","year":"2001","journal-title":"J. Hepatol."},{"issue":"9138","key":"10.1016\/j.drugalcdep.2008.12.012_bib35","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International hepatitis interventional therapy group (IHIT)","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00019053-200321050-00005","article-title":"Peginterferon alpha-2a (40kD) [Pegysis] improves HRQOL outcomes compared with unmodified interferon alpha-2a [Roferon-A] in patients with chronic hepatitis C","volume":"21","author":"Rasenack","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.drugalcdep.2008.12.012_bib37","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.mcg.0000173860.08478.a6","article-title":"Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy","volume":"39","author":"Rowan","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib38","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.1996.tb03160.x","article-title":"Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire","volume":"91","author":"Ryan","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.drugalcdep.2008.12.012_bib40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.20659","article-title":"Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment","volume":"41","author":"Spiegel","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.drugalcdep.2008.12.012_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0899-3289(99)80142-4","article-title":"The functioning and well being of persons who seek treatment for drug and alcohol use","volume":"10","author":"Stein","year":"1998","journal-title":"J. Subst. Abuse"},{"issue":"4","key":"10.1016\/j.drugalcdep.2008.12.012_bib42","first-page":"1147","article-title":"American association for the study of liver diseases","volume":"39","author":"Strader","year":"2004","journal-title":"Diagn. Manage. Treat. Hepat. C: Hepatol."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1047-2797(00)00155-1","article-title":"The mulitperson use of non-syringe injection equipment and risk of hepatitis C infection in a cohort of young adult injection drug users, Chicago 1997\u20131999","volume":"10","author":"Thorpe","year":"2000","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/aje\/155.7.645","article-title":"Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment","volume":"155","author":"Thorpe","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bmj.317.7156.433","article-title":"Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study","volume":"317","author":"vanBeek","year":"1998","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.drugalcdep.2008.12.012_bib46","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/JCM.35.12.3274-3277.1997","article-title":"Incidence and risk factors for hepatitis C among injection drug users in Baltimore","volume":"35","author":"Villano","year":"1997","journal-title":"Maryland. Clinical Microbiology."},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib47","series-title":"SF-36 Physical and Mental Health Summary Scales: A Manual for Users Version 1","author":"Ware","year":"2001"},{"key":"10.1016\/j.drugalcdep.2008.12.012_bib48","series-title":"SF-36 Health Survey: Manual & Interpretation Guide","author":"Ware","year":"2000"},{"issue":"3","key":"10.1016\/j.drugalcdep.2008.12.012_bib49","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.21565","article-title":"The effects of HCV infection and management on health-related quality of life","volume":"45","author":"Younossi","year":"2007","journal-title":"Hepatology"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871609000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871609000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T02:58:38Z","timestamp":1589597918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871609000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0376871609000179"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2008.12.012","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}